Search Results - "Yue, Huiran"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer by Yue, Huiran, Li, Wenzhi, Chen, Ruifang, Wang, Jieyu, Lu, Xin, Li, Jun

    Published in Gynecologic oncology (01-02-2021)
    “…Periostin (POSTN) overexpression observed in various cancer types is correlated with metastasis and tumor progression. However, its effect on the crosstalk…”
    Get full text
    Journal Article
  2. 2

    Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance by Yue, Huiran, Lu, Xin

    Published in Acta biochimica et biophysica Sinica (06-04-2023)
    “…Antiangiogenic therapies, such as treatment with bevacizumab, display modest survival benefits in ovarian cancer (OC) patients. After a transient response, the…”
    Get full text
    Journal Article
  3. 3

    Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer by Yue, Huiran, Wang, Jieyu, Chen, Ruifang, Hou, Xiaoman, Li, Jun, Lu, Xin

    Published in BMC cancer (30-12-2019)
    “…The clinical significance of hematogenous and lymphatic metastasis in ovarian cancer has been increasingly addressed, as it plays an imperative role in the…”
    Get full text
    Journal Article
  4. 4

    The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer by Wang, Jieyu, Zhong, Fangfang, Li, Jun, Yue, Huiran, Li, Wenzhi, Lu, Xin

    Published in Journal of translational medicine (21-01-2023)
    “…The overall survival rate of patients with advanced ovarian cancer (OC) has remained static for several decades. Advanced ovarian cancer is known for its poor…”
    Get full text
    Journal Article
  5. 5

    Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer by Li, Jun, Yue, Huiran, Yu, Hailin, Lu, Xin, Xue, Xiaohong

    Published in BMC cancer (14-01-2021)
    “…The role of nicotinamide N-methyltransferase (NNMT) in ovarian cancer is still elusive. Our aim is to explore the expression of NNMT in ovarian cancer and to…”
    Get full text
    Journal Article
  6. 6

    The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer by Zhu, Tingting, Chen, Ruifang, Wang, Jieyu, Yue, Huiran, Lu, Xin, Li, Jun

    Published in Cancer cell international (18-06-2020)
    “…Deregulation of integrins signaling had been documented to participate in multiple fundamental biological processes, and the aberrant expression of integrin…”
    Get full text
    Journal Article
  7. 7

    DNA methylation-based profiling reveals distinct clusters with survival heterogeneity in high-grade serous ovarian cancer by Wang, Jieyu, Li, Jun, Chen, Ruifang, Yue, Huiran, Li, Wenzhi, Wu, Beibei, Bai, Yang, Zhu, Guohua, Lu, Xin

    Published in Clinical epigenetics (01-12-2021)
    “…High-grade serous ovarian cancer (HGSOC) is the most common type of epigenetically heterogeneous ovarian cancer. Methylation typing has previously been used in…”
    Get full text
    Journal Article
  8. 8

    Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer by Li, Jun, Yue, Huiran, Yu, Hailin, Lu, Xin, Xue, Xiaohong

    Published in Journal of ovarian research (21-05-2019)
    “…Our aim is to analyzed the expression pattern of sirtuin(SIRT) superfamily and evaluated their prognostic values in serous ovarian cancer patients. We first…”
    Get full text
    Journal Article
  9. 9

    Bevacizumab confers significant improvements in survival for ovarian cancer patients with low miR-25 expression and high miR-142 expression by Li, Jun, Yue, Huiran, Li, Wenzhi, Zhu, Guohua, Zhu, Tingting, Chen, Ruifang, Lu, Xin

    Published in Journal of ovarian research (22-11-2021)
    “…Lymphovascular space invasion (LVSI) is the first step of hematogenous metastasis. Exploration of the differential miRNA expression profiles between…”
    Get full text
    Journal Article
  10. 10

    Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance: Metabolic reprogramming of the OC microenvironment by Yue, Huiran, Lu, Xin

    Published in Acta biochimica et biophysica Sinica (06-04-2023)
    “…Antiangiogenic therapies, such as treatment with bevacizumab, display modest survival benefits in ovarian cancer (OC) patients. After a transient response, the…”
    Get full text
    Journal Article
  11. 11

    Chemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: A multistudy analysis by Li, Jun, Yue, Huiran, Wang, Xingran, Chen, Ruifang, Lu, Xin

    “…To enable a comparison of reported chemotherapy regimens in gestational trophoblastic neoplasia (GTN) patients with a International Federation of Gynecology…”
    Get full text
    Journal Article
  12. 12

    The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/[beta]-catenin axis and acts as a therapeutic target in ovarian cancer by Wang, Jieyu, Zhong, Fangfang, Li, Jun, Yue, Huiran, Li, Wenzhi, Lu, Xin

    Published in Journal of translational medicine (21-01-2023)
    “…Background The overall survival rate of patients with advanced ovarian cancer (OC) has remained static for several decades. Advanced ovarian cancer is known…”
    Get full text
    Journal Article
  13. 13

    SNAI2 3'untranslated region promotes the invasion of ovarian cancer cells by inducing MARCKS expression by Li, Jun, Wang, Jieyu, Yue, Huiran, Lu, Xin

    Published in Journal of Cancer (01-01-2019)
    “…: Recently, accumulating evidence has indicated that the 3' untranslated regions (3'UTRs) of protein coding genes play critical roles in the progression of…”
    Get full text
    Journal Article